Is Sanofi (SNY) The Best Immunology Stock To Buy Now?
Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.
Novavax Q4 Earnings Review: Long-Term Downsizing Plan Suggests Sell Rating
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
Sanofi India shares rise 4% on strong topline and operational show, net profit sharply lower
Sanofi’s cardiovascular (CV) and central nervous system (CNS) therapies have gained traction, supported by partnerships.
Novavax's quarterly loss shrinks as it ramps down spending on COVID vaccines
The company has struggled to keep up with the pace of its rivals Moderna and Pfizer, which make messenger RNA-based vaccines ...
Canada5d
Ways to do your taxes
The Digital File My Return service is no longer available. To file your tax return, select one of the options listed below. There are several ways to do your taxes, including options that are free and ...
appliedclinicaltrialsonline6d
New Data Emerges from Phase IIb RELIEVE UCCD Study in Ulcerative Colitis and Crohn’s Disease
Following initial positive results shared by Teva and Sanofi in December 2024, new data shows duvakitug (TEV’574/SAR447189) ...